American International Group’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,952
Closed -$55.3K 1950
2024
Q1
$55.3K Buy
13,952
+53
+0.4% +$273 ﹤0.01% 2761
2023
Q4
$69.1K Sell
13,899
-56
-0.4% -$278 ﹤0.01% 2728
2023
Q3
$70.5K Buy
13,955
+497
+4% +$2.72K ﹤0.01% 2703
2023
Q2
$67.7K Buy
+13,458
New +$88.1K ﹤0.01% 2790
2018
Q2
Sell
-635
Closed -$15K 3105
2018
Q1
$15K Sell
635
-34
-5% -$9.14K ﹤0.01% 3006
2017
Q4
$125K Buy
669
+3
+0.5% +$604 ﹤0.01% 2606
2017
Q3
$143K Buy
666
+50
+8% +$10.3K ﹤0.01% 2468
2017
Q2
$126K Buy
616
+115
+23% +$22.7K ﹤0.01% 2581
2017
Q1
$91K Buy
501
+34
+7% +$6.73K ﹤0.01% 2639
2016
Q4
$117K Sell
467
-1
-0.2% -$227 ﹤0.01% 2506
2016
Q3
$97.5K Hold
468
﹤0.01% 2609
2016
Q2
$94.5K Buy
468
+224
+92% +$39.6K ﹤0.01% 2648
2016
Q1
$45K Buy
+244
New +$43.6K ﹤0.01% 3931

Other funds holding PDSB

American International Group's PDSB Position: Q2 2024 in Review

American International Group sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 13,952 shares — an estimated $55.3K sold.

American International Group first reported a position in PDSB in Q1 2016 and held it in 13 quarters. The position peaked at $143K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • American International Group reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,952 PDS Biotechnology shares in Q2 2024, an estimated $55.3K.
  • American International Group first reported a position in PDS Biotechnology in Q1 2016 and held it in 13 quarters.
  • American International Group's PDS Biotechnology position peaked at $143K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.